Melinda Richter

Meet Melinda Richter

“Improving access to medicines starts with shortening the amount of time it takes to get a therapeutic into the hands of the patient or consumer. Typically, that process can take up to ten years and millions or even billions of dollars. This has to change! I’ve worked tirelessly to streamline this process for healthcare entrepreneurs, via our Johnson & Johnson Innovation – JLABS model, and will continue to work to shorten that development cycle and to make it more affordable to ultimately get medicines into the hands of those who need them most.”